Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Meliessa Hennessy
Efficacy and Safety of First-Line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma
JAMA Oncology
Cancer Research
Oncology
Updated Efficacy of Avelumab in Patients With Previously Treated Metastatic Merkel Cell Carcinoma After ≥1 Year of Follow-Up: JAVELIN Merkel 200, a Phase 2 Clinical Trial
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Related publications
PD-L1 Inhibition With Avelumab for Metastatic Merkel Cell Carcinoma
Expert Review of Clinical Pharmacology
Medicine
Toxicology
Pharmaceutics
Pharmacology
Minimal Impact on Patients’ Health Utilities Associated With Adverse Events in Metastatic Merkel Cell Carcinoma Patients on Treatment With Avelumab
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Avelumab in the Treatment of Patients With Merkel Cell Carcinoma: Initial Results of Early Access Program in Russia
Malignant tumours
Mo2 - Modelling Overall Survival in Immunotherapy Using Parametric Techniques: Avelumab in Previously Treated Metastatic Merkel Cell Carcinoma
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Diffuse Lichen Planus-Like Keratoses and Clinical Pseudo-Progression Associated With Avelumab Treatment for Merkel Cell Carcinoma, a Case Report
BMC Cancer
Cancer Research
Oncology
Genetics
Development and Validation of a Prognostic Index for Efficacy Evaluation and Prognosis of First-Line Chemotherapy in Stage III–IV Lung Squamous Cell Carcinoma
European Radiology
Medicine
Nuclear Medicine
Radiology
Imaging
Do Tyrosine Kinase Inhibitors Lose Favor in Treatment of First-Line Metastatic Renal Cell Carcinoma?
Future Oncology
Medicine
Cancer Research
Oncology
Immunotherapy for the First-Line Treatment of Patients With Metastatic Non-Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
